Longitudinal evaluation of upper extremity reachable workspace in ALS by Kinect sensor

Evan de Bie, Bjorn Oskarsson, Nanette C. Joyce, Alina Nicorici, Gregorij Kurillo, Jay J. Han

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Our objective was to evaluate longitudinal changes in Microsoft Kinect measured upper extremity reachable workspace relative surface area (RSA) versus the revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R), ALSFRS-R upper extremity sub-scale and Forced Vital Capacity (FVC) in a cohort of patients diagnosed with amyotrophic lateral sclerosis (ALS). Ten patients diagnosed with ALS (ages 52–76 years, ALSFRS-R: 8–41 at entry) were tested using single 3D depth sensor, Microsoft Kinect, to measure reachable workspace RSA across five visits spanning one year. Changes in RSA, ALSFRS-R, ALSFRS-R upper extremity sub-scale, and FVC were assessed using a linear mixed model. Results showed that upper lateral quadrant RSA declined significantly in one year by approximately 19% (p <0.01) while all other quadrants and total RSA did not change significantly in this time-period. Simultaneously, ALSFRS-R upper extremity sub-scale worsened significantly by 25% (p <0.01). In conclusion, upper extremity reachable workspace RSA as a novel ALS outcome measure is capable of objectively quantifying declines in upper extremity ability over time in patients with ALS with more granularity than other common outcome measures. RSA may serve as a clinical endpoint for the evaluation of upper extremity targeted therapeutics.

Original languageEnglish (US)
Pages (from-to)17-23
Number of pages7
JournalAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Volume18
Issue number1-2
DOIs
StatePublished - Jan 2 2017

Fingerprint

Amyotrophic Lateral Sclerosis
Upper Extremity
Vital Capacity
Outcome Assessment (Health Care)
Linear Models

Keywords

  • ALS
  • Kinect
  • longitudinal
  • motor activity
  • outcome measure
  • Reachable workspace
  • upper extremity

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Longitudinal evaluation of upper extremity reachable workspace in ALS by Kinect sensor. / de Bie, Evan; Oskarsson, Bjorn; Joyce, Nanette C.; Nicorici, Alina; Kurillo, Gregorij; Han, Jay J.

In: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 18, No. 1-2, 02.01.2017, p. 17-23.

Research output: Contribution to journalArticle

de Bie, Evan ; Oskarsson, Bjorn ; Joyce, Nanette C. ; Nicorici, Alina ; Kurillo, Gregorij ; Han, Jay J. / Longitudinal evaluation of upper extremity reachable workspace in ALS by Kinect sensor. In: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2017 ; Vol. 18, No. 1-2. pp. 17-23.
@article{f431108e7d88492ca425e72cfe61a29e,
title = "Longitudinal evaluation of upper extremity reachable workspace in ALS by Kinect sensor",
abstract = "Our objective was to evaluate longitudinal changes in Microsoft Kinect measured upper extremity reachable workspace relative surface area (RSA) versus the revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R), ALSFRS-R upper extremity sub-scale and Forced Vital Capacity (FVC) in a cohort of patients diagnosed with amyotrophic lateral sclerosis (ALS). Ten patients diagnosed with ALS (ages 52–76 years, ALSFRS-R: 8–41 at entry) were tested using single 3D depth sensor, Microsoft Kinect, to measure reachable workspace RSA across five visits spanning one year. Changes in RSA, ALSFRS-R, ALSFRS-R upper extremity sub-scale, and FVC were assessed using a linear mixed model. Results showed that upper lateral quadrant RSA declined significantly in one year by approximately 19{\%} (p <0.01) while all other quadrants and total RSA did not change significantly in this time-period. Simultaneously, ALSFRS-R upper extremity sub-scale worsened significantly by 25{\%} (p <0.01). In conclusion, upper extremity reachable workspace RSA as a novel ALS outcome measure is capable of objectively quantifying declines in upper extremity ability over time in patients with ALS with more granularity than other common outcome measures. RSA may serve as a clinical endpoint for the evaluation of upper extremity targeted therapeutics.",
keywords = "ALS, Kinect, longitudinal, motor activity, outcome measure, Reachable workspace, upper extremity",
author = "{de Bie}, Evan and Bjorn Oskarsson and Joyce, {Nanette C.} and Alina Nicorici and Gregorij Kurillo and Han, {Jay J.}",
year = "2017",
month = "1",
day = "2",
doi = "10.1080/21678421.2016.1241278",
language = "English (US)",
volume = "18",
pages = "17--23",
journal = "Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration",
issn = "2167-8421",
publisher = "Informa Healthcare",
number = "1-2",

}

TY - JOUR

T1 - Longitudinal evaluation of upper extremity reachable workspace in ALS by Kinect sensor

AU - de Bie, Evan

AU - Oskarsson, Bjorn

AU - Joyce, Nanette C.

AU - Nicorici, Alina

AU - Kurillo, Gregorij

AU - Han, Jay J.

PY - 2017/1/2

Y1 - 2017/1/2

N2 - Our objective was to evaluate longitudinal changes in Microsoft Kinect measured upper extremity reachable workspace relative surface area (RSA) versus the revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R), ALSFRS-R upper extremity sub-scale and Forced Vital Capacity (FVC) in a cohort of patients diagnosed with amyotrophic lateral sclerosis (ALS). Ten patients diagnosed with ALS (ages 52–76 years, ALSFRS-R: 8–41 at entry) were tested using single 3D depth sensor, Microsoft Kinect, to measure reachable workspace RSA across five visits spanning one year. Changes in RSA, ALSFRS-R, ALSFRS-R upper extremity sub-scale, and FVC were assessed using a linear mixed model. Results showed that upper lateral quadrant RSA declined significantly in one year by approximately 19% (p <0.01) while all other quadrants and total RSA did not change significantly in this time-period. Simultaneously, ALSFRS-R upper extremity sub-scale worsened significantly by 25% (p <0.01). In conclusion, upper extremity reachable workspace RSA as a novel ALS outcome measure is capable of objectively quantifying declines in upper extremity ability over time in patients with ALS with more granularity than other common outcome measures. RSA may serve as a clinical endpoint for the evaluation of upper extremity targeted therapeutics.

AB - Our objective was to evaluate longitudinal changes in Microsoft Kinect measured upper extremity reachable workspace relative surface area (RSA) versus the revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R), ALSFRS-R upper extremity sub-scale and Forced Vital Capacity (FVC) in a cohort of patients diagnosed with amyotrophic lateral sclerosis (ALS). Ten patients diagnosed with ALS (ages 52–76 years, ALSFRS-R: 8–41 at entry) were tested using single 3D depth sensor, Microsoft Kinect, to measure reachable workspace RSA across five visits spanning one year. Changes in RSA, ALSFRS-R, ALSFRS-R upper extremity sub-scale, and FVC were assessed using a linear mixed model. Results showed that upper lateral quadrant RSA declined significantly in one year by approximately 19% (p <0.01) while all other quadrants and total RSA did not change significantly in this time-period. Simultaneously, ALSFRS-R upper extremity sub-scale worsened significantly by 25% (p <0.01). In conclusion, upper extremity reachable workspace RSA as a novel ALS outcome measure is capable of objectively quantifying declines in upper extremity ability over time in patients with ALS with more granularity than other common outcome measures. RSA may serve as a clinical endpoint for the evaluation of upper extremity targeted therapeutics.

KW - ALS

KW - Kinect

KW - longitudinal

KW - motor activity

KW - outcome measure

KW - Reachable workspace

KW - upper extremity

UR - http://www.scopus.com/inward/record.url?scp=84994112816&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994112816&partnerID=8YFLogxK

U2 - 10.1080/21678421.2016.1241278

DO - 10.1080/21678421.2016.1241278

M3 - Article

C2 - 27813421

AN - SCOPUS:84994112816

VL - 18

SP - 17

EP - 23

JO - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

JF - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

SN - 2167-8421

IS - 1-2

ER -